ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,424Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 487

$447K Total Retail Price of All Prescriptions

Rank: 53 out of 487

373 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,747 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
OMEPRAZOLE 374 304 1 2
LEVOTHYROXINE SODIUM 359 316 2 1
HYDROCODONE-ACETAMINOPHEN 311 233 S3 3 3
FUROSEMIDE 270 261 4 7
SIMVASTATIN 235 203 5 4
LISINOPRIL 164 146 6 5
CITALOPRAM HBR 155 147 7 12
HYDROCHLOROTHIAZIDE 124 91 8 9
GABAPENTIN 121 91 9 13
AMLODIPINE BESYLATE 120 101 10 6
SPIRONOLACTONE 118 114 11 43
PREDNISONE 117 114 12 37
METFORMIN HCL 116 83 13 8
TAMSULOSIN HCL 114 102 14 25
POTASSIUM CHLORIDE 106 105 15 10
ZOLPIDEM TARTRATE 101 73 16 14
FLUTICASONE PROPIONATE 98 82 17 33
FLUOXETINE HCL 92 43 18 28
RISPERIDONE 90 57 19 58
MISOPROSTOL 85 60 20 207
PANTOPRAZOLE SODIUM 82 71 21 62
SERTRALINE HCL 81 35 22 21
FENTANYL 80 65 S2 23 36
DICLOFENAC SODIUM 77 62 24 112
ALLOPURINOL 77 73 24 29
CARVEDILOL 76 54 26 32
WARFARIN SODIUM 76 75 26 11
ISOSORBIDE MONONITRATE ER 73 73 28 79
RANITIDINE HCL 71 50 29 39
ESTRADIOL 70 51 R 30 68
TRAMADOL HCL 69 58 31 19
POLYETHYLENE GLYCOL 3350 65 58 32 56
OXYCODONE HCL 65 12 S2 32 57
GLIMEPIRIDE 64 61 34 35
METOPROLOL TARTRATE 64 64 34 17
LIOTHYRONINE SODIUM 63 55 36 161
LANTUS 63 47 36 44
PRAMIPEXOLE DIHYDROCHLORIDE 63 59 36 141
LOSARTAN POTASSIUM 63 48 36 16
ATENOLOL 60 56 40 23
MIRTAZAPINE 60 38 40 59
METOCLOPRAMIDE HCL 59 41 42 111
ROPINIROLE HCL 58 49 43 60
METOPROLOL SUCCINATE 56 56 44 15
MELOXICAM 52 38 45 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.